In experimental PDAC models, CSF1/CSF1R signalling in pancreatic tumours depletes CD206Hi TAMs and reprograms remaining macrophages to support anti‐tumour immunity.43 This evidence concerns the gene CSF1R and pancreatic neoplasm.